Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell linesKazuya Takahashi(University of Yamanashi), Kanji Sugita(University of Yamanashi)PLoS ONEDecember 13, 201710.1371/journal.pone.0188680Cited by 50SaveCiteExport RISWatch citationsRelated PapersInflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression|Cell Death and Disease|2017|12IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform|Cell Death Discovery|2021|2